Analysts Lower Targets for GoodRx Amid Sector Adjustments
Bank of America, Morgan Stanley, and Barclays have reduced price targets for GoodRx Holdings in recent weeks, while expressing varied outlooks on the broader healthcare sector.
Topic
Latest reporting and analysis tagged with stock analysis.
Bank of America, Morgan Stanley, and Barclays have reduced price targets for GoodRx Holdings in recent weeks, while expressing varied outlooks on the broader healthcare sector.
Freedom Capital initiated coverage of Gambling.com with a Buy rating and $8.50 target. Q3 2025 revenue rose 21% to $39M, driven by sports data, but marketing headwinds led to revised guidance.
Several energy stocks present analyst upside targets for 2026, including Cheniere Energy with 40% potential, Diamondback Energy's $1.76B Q3 free cash flow, and Devon Energy beating earnings estimates.
Analysts from D.A. Davidson, Piper Sandler, and Truist Securities identify software companies poised to lead a market recovery, focusing on AI infrastructure and shifting pricing models.
An analyst compares options trading to football formations, then details specific bull call spreads for HPE, Snowflake, and CrowdStrike based on recent price patterns and quantitative signals.